FDA
-
-
-
-
-
-
-
Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results
-
-
-
-
-
-
-
Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin
-
-
-
-
-
-
-
Codexis Reports First Quarter 2020 Financial Results
-
-
-
-
-
-
-
Codexis (CDXS) Receives Notice from FDA that it Completed Safety Review of IND Application for CDX-6114
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

